Viewing Study NCT02483104


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-02-20 @ 10:45 PM
Study NCT ID: NCT02483104
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M14-488
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators